xCures
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis | — | 2024-06-10 |
| Recruiting | xPedite: A Study to Expedite DIPG and DMG Research Oncology, DIPG, DMG | — | 2023-11-01 |
| Terminated | Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib Bladder Cancer, Urothelial Carcinoma, Transitional Cell Carcinoma | — | 2021-11-21 |
| Completed | Behavior, Environment And Treatments for Covid-19 Coronavirus | — | 2020-03-21 |
| Unknown | A Patient-Centric Platform Trial for Precision Oncology Oncology | — | 2019-02-07 |
| Available | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer | — | — |